The short version of Reference standard fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-06 and is reviewed periodically as new material appears.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common for reference-grade material. |
| Solubility | Low in water | Dissolves in DMSO and some organic solvents. |
| Typical storage | -20 °C, desiccated | Protect from light and moisture. |
| Analytical method | LC-MS/MS | Used for trace detection in biological matrices. |
| Purity assessment | HPLC with UV detection | Often combined with NMR and mass spectrometry. |
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
== S == safe sex – safer sex – salmonella – salvage therapy – SAMHSA – sarcoma – seborrheic dermatitis – secondary prophylaxis – sepsis – seroconversion – serologic test – seroprevalence – serosorting – serostatus – serum – serum glutamic oxaloacetic transaminase (SGOT) – serum glutamic pyruvate transaminase (SGPT) – sexually transmitted disease (STD) – shingles – SHIV – side effects – simian immunodeficiency virus (SIV) – sinusitis – social integration SIT – SIV – Special Projects of National Significance (SPNS) – spinal tap – spleen – splenomegaly – sputum analysis – standard of care – staphylococcus – STD – stem cells (FDCs) – steroid – Stevens–Johnson syndrome – STI – stomatitis – strain – stratification – structured intermittent therapy (SIT) – structured treatment interruption (STI) – study endpoint – subarachnoid space – subclinical infection – subcutaneous (SQ) – Substance Abuse and Mental Health Services Administration (SAMHSA) – subunit HIV vaccine – sulfa drug – sulfonamides – superantigen – suppressor T cell – surrogate marker – surveillance – susceptible – symptoms – syncytium – syndrome – synergy – synergistic – synthesis – syphilis – systemic
== Background == The measurement of scattered light from an illuminated sample forms the basis of the so-called classical light scattering measurement. Historically, such measurements were made using a single detector rotated in an arc about the illuminated sample. The first commercial instrument (formally called a "scattered photometer") was the Brice-Phoenix light scattering photometer introduced in the mid-1950s and followed by the Sofica photometer introduced in the late 1960s. Measurements were generally expressed as scattered intensities or scattered irradiance. Since the collection of data was made as the detector was placed at different locations on the arc, each position corresponding to a different scattering angle, the concept of placing a separate detector at each angular location of interest was well understood, though not implemented commercially until the late 1970s. Multiple detectors having different quantum efficiency have different response and hence needs to be normalized in this scheme. An interesting system based upon the use of high speed film was developed by Brunsting and Mullaney in 1974. It permitted the entire range of scattered intensities to be recorded on the film with a subsequent densitometer scan providing the relative scattered intensities. The then-conventional use of a single detector rotated about an illuminated sample with intensities collected at specific angles was called differential light scattering after the quantum mechanical term differential cross section, σ(θ) expressed in milli-barns/steradian.
The members of an alkylation series have the same degree of unsaturation and number of heteroatoms (nitrogen, oxygen and sulfur) but differ in the number of CH2 units. Members of an alkylation series have the same Kendrick mass defect. The Kendrick mass defect has also been defined as
Fluphenazine was the third antipsychotic FDA approved in the United States in 1959, and 9 years later was the first FDA approved injectable antipsychotic. The injectable form is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. It was discontinued in Australia in 2017.
=== Synthesis and reactions === Several methods exist for the laboratory synthesis of dimethyl fumarate, with reported methods including alkene isomerization of dimethyl maleate, and Fischer esterification of fumaric acid. Dimethyl fumarate is an old compound used in industrial chemistry and can be purchased by the ton; as of 2012, one could purchase it for $1 to $50 per metric ton, with a two-ton minimum purchase. The compound undergoes electrohydrodimerization.
Sources: en.wikipedia.org
Currently, there is a Taco Bell location across the street at 7127 Firestone Blvd, in Downey, which opened in 1996. The oldest operating Taco Bell location is store #2 (now operating as store #40400) at 1822 Santa Fe, in Long Beach, CA, which opened on August 7, 1962. Initially designed exactly like "Numero Uno", the building has since been remodeled extensively. Two former "Numero Uno" buildings still operate as other businesses, including another one in Long Beach, California (opened in early 1963), and one in Hawaiian Gardens, California (opened as store #3 in September 1962).
Sunobinop (developmental code names V117957; IMB-115) is a high affinity small molecule nociceptin receptor partial agonist. As of February 2024, it is under clinical investigation for the treatment of insomnia, alcohol use disorder, interstitial cystitis, and overactive bladder syndrome. It was previously also under investigation for the treatment of fibromyalgia.
== Opposition to atomic theory == Dalton's atomic theory attracted widespread interest but not universal acceptance. One problem was the lack of uniform nomenclature. The word "atom" implied indivisibility, but Dalton defined an atom as being the ultimate particle of any chemical substance, not just the elements or even matter per se. This meant that "compound atoms" such as carbon dioxide could be divided, as opposed to "elementary atoms". Dalton disliked the word "molecule", regarding it as "diminutive". Amedeo Avogadro did the opposite: he exclusively used the word "molecule" in his writings, eschewing the word "atom", instead using the term "elementary molecule". Jöns Jacob Berzelius used the term "organic atoms" to refer to particles containing three or more elements, because he thought this only existed in organic compounds. Jean-Baptiste Dumas used the terms "physical atoms" and "chemical atoms"; a "physical atom" was a particle that cannot be divided by physical means such as temperature and pressure, and a "chemical atom" was a particle that could not be divided by chemical reactions. The modern definitions of atom and molecule—an atom being the basic particle of an element, and a molecule being an agglomeration of atoms—were established in the latter half of the 19th century. A key event was the Karlsruhe Congress in Germany in 1860. As the first international congress of chemists, its goal was to establish some standards in the community. A major proponent of the modern distinction between atoms and molecules was Stanislao Cannizzaro.
==== Saddam Hussein ==== In July 2007, the New Statesman printed selected portions of a 1976 piece by Hitchens which they claimed "took a more admiring view of the Iraqi dictator" than his later strong support for ousting Saddam Hussein. In this Hitchens pointed to Iraq's military strength, oil reserves and young leadership to argue that Iraq was "a force to be reckoned with" and described Saddam Hussein as a leader "who has sprung from being an underground revolutionary gunman to perhaps the first visionary Arab statesman since Nasser." He also argued:
There is insufficient evidence to show that whether applying cyanoacrylate microbial sealants on the wound site before operation is effective in reducing surgical site infection post surgery. There is no evidence that one type of hand antisepsis is better than the other in preventing surgical site infection. There is no evidence that plastic adhesive tapes reduces surgical site infections.
Sources: en.wikipedia.org
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.
Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.
No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.